QIM
SUPN icon

Quantitative Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Quantitative Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-23,554
Closed -$559K – 584
2020
Q2 		$559K Buy
+23,554
New +$520K 0.06% 320
2018
Q3 		– Sell
-97,100
Closed -$5.81M – 861
2018
Q2 		$5.81M Buy
97,100
+48,900
+101% +$2.53M 0.12% 172
2018
Q1 		$2.21M Buy
+48,200
New +$2.01M 0.04% 434

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Quantitative Investment Management's SUPN Position: Q3 2020 in Review

Quantitative Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2020, closing a stake of 23,554 shares — an estimated $559K sold.

Quantitative Investment Management first reported a position in SUPN in Q1 2018 and held it in 3 quarters. The position peaked at $5.81M in Q2 2018. 209 funds tracked by Wall St. Rank hold SUPN as of Q3 2020.

  • Quantitative Investment Management reported no remaining Supernus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 23,554 Supernus Pharmaceuticals shares in Q3 2020, an estimated $559K.
  • Quantitative Investment Management first reported a position in Supernus Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Quantitative Investment Management's Supernus Pharmaceuticals position peaked at $5.81M in Q2 2018.
  • 209 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2020.

Based on Quantitative Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.